Revvity, Inc. (BIT:1RVTY)
Italy flag Italy · Delayed Price · Currency is EUR
80.52
-0.76 (-0.94%)
At close: May 30, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 2014 - 2020
Period Ending
Mar '25 Dec '24 Dec '23 Jan '23 Jan '22 2014 - 2020
Discovery & Analytical Solutions Product Revenue (Pre-Q3 2022)
-
Log In
Log In
Log In
Log In
Upgrade
Discovery & Analytical Solutions Product Revenue (Pre-Q3 2022) Growth
-
Log In
Log In
Log In
Log In
Upgrade
Discovery & Analytical Solutions Service Revenue (Pre-Q3 2022)
-
Log In
Log In
Log In
Log In
Upgrade
Discovery & Analytical Solutions Service Revenue (Pre-Q3 2022) Growth
-
Log In
Log In
Log In
Log In
Upgrade
Total Discovery & Analytical Solutions Revenue (Pre-Q3 2022)
-
Log In
Log In
Log In
Log In
Upgrade
Total Discovery & Analytical Solutions Revenue (Pre-Q3 2022) Growth
-
Log In
Log In
Log In
Log In
Upgrade
Diagnostics Product Revenue (Pre-Q3 2022)
-
Log In
Log In
Log In
Log In
Upgrade
Diagnostics Product Revenue (Pre-Q3 2022) Growth
-
Log In
Log In
Log In
Log In
Upgrade
Diagnostics Service Revenue (Pre-Q3 2022)
-
Log In
Log In
Log In
Log In
Upgrade
Diagnostics Service Revenue (Pre-Q3 2022) Growth
-
Log In
Log In
Log In
Log In
Upgrade
Total Discovery & Analytical Solutions Revenue (Post-Q2 2022)
1.29B
Log In
Log In
Log In
Log In
Upgrade
Total Discovery & Analytical Solutions Revenue (Post-Q2 2022) Growth
-0.69%
Log In
Log In
Log In
Log In
Upgrade
Total Diagnostics Revenue (Pre-Q3 2022)
1.48B
Log In
Log In
Log In
Log In
Upgrade
Total Diagnostics Revenue (Pre-Q3 2022) Growth
3.73%
Log In
Log In
Log In
Log In
Upgrade
Total Product
2.34B
Log In
Log In
Log In
Log In
Upgrade
Total Product Growth
-1.57%
Log In
Log In
Log In
Log In
Upgrade
Total Service
434.73M
Log In
Log In
Log In
Log In
Upgrade
Total Service Growth
23.09%
Log In
Log In
Log In
Log In
Upgrade
Life Sciences Revenue (Pre-Q3 2022)
-
Log In
Log In
Log In
Log In
Upgrade
Life Sciences Revenue (Pre-Q3 2022) Growth
-
Log In
Log In
Log In
Log In
Upgrade
Applied Markets Revenue (Pre-Q3 2022)
-
Log In
Log In
Log In
Log In
Upgrade
Applied Markets Revenue (Pre-Q3 2022) Growth
-
Log In
Log In
Log In
Log In
Upgrade

EBIT by Product

Fiscal year is January - December.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 2014 - 2020
Period Ending
Mar '25 Dec '24 Dec '23 Jan '23 Jan '22 2014 - 2020
Discovery & Analytical Solutions Operating Income (Pre-Q3 2022)
-
Log In
Log In
Log In
Log In
Upgrade
Discovery & Analytical Solutions Operating Income (Pre-Q3 2022) Growth
-
Log In
Log In
Log In
Log In
Upgrade
Discovery & Analytical Solutions Operating Income (Post-Q2 2022)
452.01M
Log In
Log In
Log In
Log In
Upgrade
Discovery & Analytical Solutions Operating Income (Post-Q2 2022) Growth
-1.92%
Log In
Log In
Log In
Log In
Upgrade
Diagnostics Operating Income (Pre-Q3 2022)
371.78M
Log In
Log In
Log In
Log In
Upgrade
Diagnostics Operating Income (Pre-Q3 2022) Growth
15.21%
Log In
Log In
Log In
Log In
Upgrade